CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma (Q39000882)

8 September 2017

title

CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma (English)

1 reference

8 September 2017

1 reference

Nadine Hömberg

1

1 reference

8 September 2017

Christian Adam

2

1 reference

8 September 2017

Tanja Riedel

3

1 reference

8 September 2017

Christoph Brenner

4

1 reference

8 September 2017

Andrew Flatley

5

1 reference

8 September 2017

Martin Röcken

6

1 reference

8 September 2017

Ralph Mocikat

7

1 reference

8 September 2017

language of work or name

English

0 references

publication date

8 May 2014

1 reference

International Journal of Cancer

8 September 2017

published in

1 reference

8 September 2017

volume

135

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

2825-2833

1 reference

Dendritic cells and the control of immunity

8 September 2017

cites work

1 reference

Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor

21 January 2018

1 reference

The role of the CD28 receptor during T cell responses to antigen

21 January 2018

1 reference

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

21 January 2018

1 reference

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine.

21 January 2018

1 reference

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

21 January 2018

1 reference

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells

21 January 2018

1 reference

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

21 January 2018

1 reference

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

21 January 2018

1 reference

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

21 January 2018

1 reference

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction

21 January 2018

1 reference

Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells

21 January 2018

1 reference

DC therapy induces long-term NK reactivity to tumors via host DC.

21 January 2018

1 reference

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

21 January 2018

1 reference

Dendritic cell-induced activation of adaptive and innate antitumor immunity

21 January 2018

1 reference

Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice.

21 January 2018

1 reference

Requirements for control of B-cell lymphoma by NK cells

21 January 2018

1 reference

Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells

21 January 2018

1 reference

Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2.

21 January 2018

1 reference

Burkitt lymphoma in the mouse.

21 January 2018

1 reference

Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: implications for therapeutic cell transfer.

21 January 2018

1 reference

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

21 January 2018

1 reference

NK cell and DC interactions

21 January 2018

1 reference

T-helper-1-cell cytokines drive cancer into senescence

21 January 2018

1 reference

TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis

21 January 2018

1 reference

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28932

1 reference

8 September 2017

1 reference